Growth Hormone Reduces Abdominal Fat, Cardiovascular Risk In HIV Patients On Antiviral Therapy
Tuesday, August 5, 2008 - 21:35
in Health & Medicine
Low-dose growth hormone treatment reduced abdominal fat deposits and improved blood pressure and triglyceride levels in a group of patients with HIV lipodystrophy -- a condition involving the redistribution of fat and other metabolic changes in patients receiving combination drug therapy for HIV infection -- but growth hormone treatment also appeared to increase blood glucose levels, particularly in those already exhibiting glucose intolerance.
Read the whole article on Science Daily
More from Science Daily
Related
- Growth hormone reduces abdominal fat, cardiovascular risk in HIV patients on antiviral therapySun, 3 Aug 2008, 11:35:43 EDT
- Growth hormone treatment for HIV patients improves abdominal fat, but worsens glucose levelSun, 3 Aug 2008, 11:35:41 EDT
- Hormone level may reflect mortality risk among dialysis patientsWed, 6 Aug 2008, 17:29:02 EDT
- Hormone therapy helps short children grow upThu, 6 Nov 2008, 9:17:36 EST
- Blood cholesterol levels predict risk of heart disease due to hormone therapyFri, 23 May 2008, 14:35:54 EDT